Genome Insight: Funding, Investors & Team (Oct 2026)
Genome Insight is a company that offers whole genome sequencing services, which aims to provide a complete understanding of a patient's genetic makeup through the analysis and interpretation of their entire genome. With a primary focus on cancer and rare diseases, our goal is to revolutionize the treatment of genetically influenced illnesses by utilizing an unmatched database of whole genome sequencing information and a unified platform for generating, gathering, and examining genomic data.
Genome Insight has raised $27.5M across 2 funding rounds on record, the most recent a Series B of $23.0M announced in Nov 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genome Insight Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Genome Insight Funding Rounds
Genome Insight raised $4.5M in an undisclosed round announced in Jun 2023.
5 months later, a Series B of $23.0M was announced in Nov 2023.
Genome Insight Founders and Leadership Team
Contact details for the Genome Insight team: 1 of 2 have an email address on file.
Start 14-day free trial →Genome Insight Funding Compared to Other Biotechnology Startups
Genome Insight's latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genome Insight in Biotechnology and La Jolla
Companies Similar to Genome Insight
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Genome Insight Funding FAQs
What does Genome Insight do?
Genome Insight is a company that offers whole genome sequencing services, which aims to provide a complete understanding of a patient's genetic makeup through the analysis and interpretation of their entire genome. With a primary focus on cancer and rare diseases, our goal is to revolutionize the treatment of genetically influenced illnesses by utilizing an unmatched database of whole genome sequencing information and a unified platform for generating, gathering, and examining genomic data.
How much funding has Genome Insight raised?
Genome Insight has raised $27.5M across 2 rounds on record. The most recent is a Series B of $23.0M announced in Nov 2023.
When did Genome Insight last raise funding?
Genome Insight's most recent funding round on record is a Series B of $23.0M, announced in Nov 2023.
Who founded Genome Insight?
FundedIQ lists Jeong Seok Lee (Founder) at Genome Insight.
Who is the CEO of Genome Insight?
Jehee Suh is listed as CEO at Genome Insight.
Where is Genome Insight headquartered?
Genome Insight is based in La Jolla, California, United States.
How many employees does Genome Insight have?
Genome Insight is in the 51-100 employee band.
How does Genome Insight's funding compare to other Biotechnology startups?
Genome Insight's latest round of $23.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Genome Insight Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genome Insight is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.